86
65
Growth Score
-3 pts
Heat Score
30 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
311481
SCIRENT is a contract research organization that specializes in offering a range of clinical trial services for cardiovascular diseases.
- Wilhelm Haverkamp: Chief Medical Officer
- Hans-Dirk Düngen: CEO, Founder, and Scientific Director
About the Company
SCIRENT was founded in 2012 with the vision of helping customers develop innovative medical drugs and devices for patients with cardiovascular diseases. Our dedicated team of experienced clinical and regulatory professionals share their enthusiasm for developing effective therapies for cardiac patients. What sets us apart from our competitors is
our profound expertise in cardiovascular therapy and diagnostics. Our CRO offers access to an impeccable network of dedicated trial centers in Europe and North America with extensive experience in cardiovascular studies. Our customers appreciate our lean and agile management, which generally makes our performance faster and more efficient.
